Histamine and antihistamines in atopic dermatitis

Advances in Experimental Medicine and Biology

Volumn 709, Issue , 2010, Pages 73-80

  Buddenkotte, Jörg ^b   Maurer, Marcus ^b   Steinhoff, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; ANTIHISTAMINIC AGENT; CALCINEURIN INHIBITOR; CETIRIZINE; CHLORPHENIRAMINE; CLEMASTINE; CORTICOSTEROID; DOXEPIN; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; PLACEBO; PROMETHAZINE;

ARTICLE; ATOPIC DERMATITIS; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; HISTAMINE RELEASE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PRURITUS; SEDATION; SIDE EFFECT; SYMPTOM;

EID: 79960746096     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8056-4_8     Document Type: Article

References (63)

1. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008; 88:1183-241.
2. Dale HH, Laidlaw PP. The physiological action of beta- iminazolylethylamine. J Physiol 1910; 41:318-44.
3. Simons FE. Advances in H1-antihistamines. N Engl J Med 2004; 351:2203-17.
4. Greaves MW, Sabroe RA. Histamine: The quintessential mediator. J Dermatol 1996; 23:735-40. (Pubitemid 26414729)
5. Lewis T. The blood vessels of the human skin and their responses. London: Shaw and Sons, 1927.
6. Lewis T, Grant RT, Marvin HM. Vascular reactions of the skin to injury. Heart 1929; 14:139-60.
7. Hill SJ. Distribution, properties and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990; 42:45-83. (Pubitemid 20209593)
8. Malaviya R, Morrison AR, Pentland AP. Histamine in human epidermal cells is induced by ultraviolet light injury. J Invest Dermatol 1996; 106:785-9. (Pubitemid 26119741)
9. Akdis CA, Simons FE. Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 2006; 533:69-76. (Pubitemid 43340005)
10. de Esch IJ, Thurmond RL, Jongejan A et al. The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci 2005; 26:462-9. (Pubitemid 41207878)
11. Stander S, Weisshaar E, Luger TA. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol 2008; 17:161-9. (Pubitemid 351233860)
12. O'Donoghue M, Tharp MD. Antihistamines and their role as antipruritics. Dermatol Ther 2005; 18:333-40. (Pubitemid 41801853)
13. Greaves MW. Antihistamines in dermatology. Skin Pharmacol Physiol 2005; 18:220-9. (Pubitemid 41159953)
14. Dijkstra D, Stark H, Chazot PL et al. Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor. J Invest Dermatol 2008; 128:1696-703. (Pubitemid 351847377)
15. Bell JK, McQueen DS, Rees JL. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br J Pharmacol 2004; 142:374-80. (Pubitemid 38750189)
16. Roosterman D, Goerge T, Schneider SW et al. Neuronal control of skin function: The skin as a neuroimmunoendocrine organ. Physiol Rev 2006; 86:1309-79. (Pubitemid 44523706)
17. Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000; 25:522-9. (Pubitemid 32104617)
18. Horii KA, Simon SD, Liu DY et al. Atopic dermatitis in children in the United States, 1997-2004: Visit trends, patient and provider characteristics and prescribing patterns. Pediatrics 2007; 120:e527-34. (Pubitemid 47358264)
19. Darsow U, Lubbe J, Taieb A et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005; 19:286-95. (Pubitemid 40691704)
20. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92:S44-S7.
21. Hanifin JM, Cooper KD, Ho VC et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol 2004; 50:391-404.
22. Maintz L, Benfadal S, Allam JP et al. Evidence for a reduced histamine degradation capacity in a subgroup of patients with atopic eczema. J Allergy Clin Immunol 2006; 117:1106-12.
23. Worm M, Fiedler EM, Dolle S et al. Exogenous histamine aggravates eczema in a subgroup of patients with atopic dermatitis. Acta Derm Venereol 2009; 89:52-6.
24. Nahm DH, Lee ES, Park HJ et al. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex. Int Arch Allerg y Immunol 2008; 146:235-40. (Pubitemid 351832466)
25. Herman SM, Vender RB. Antihistamines in the treatment of dermatitis. J Cutan Med Surg 2003; 7:467-73.
26. Ikoma A. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: Mechanisms and management of itch in atopic dermatitis. J Pharmacol Sci 2009; 110:265-9.
27. Johnson HH, Jr., Deoreo GA, Lascheid WP et al. Skin histamine levels in chronic atopic dermatitis. J Invest Dermatol 1960; 34:237-8.
28. Juhlin L. Localization and content of histamine in normal and diseased skin. Acta Derm Venereol 1967; 47:383-91.
29. Reitamo S, Ansel JC, Luger TA. Itch in atopic dermatitis. J Am Acad Dermatol 2001; 45:S55-6. (Pubitemid 32661829)
30. Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999; 135:1522-5.
31. Munday J, Bloomfield R, Goldman M et al. Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. Dermatology 2002; 205:40-5. (Pubitemid 36152960)
32. Rukwied R, Lischetzki G, McGlone F et al. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: A dermal microdialysis study. Br J Dermatol 2000; 142:1114-20. (Pubitemid 30418296)
33. Hanifin JM. The role of antihistamines in atopic dermatitis. J Allergy Clin Immunol 1990; 86:666-9.
34. Heyer G, Hornstein OP, Handwerker HO. Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls. J Invest Dermatol 1989; 93:492-6. (Pubitemid 19225494)
35. Uehara M. Reduced histamine reaction in atopic dermatitis. Arch Dermatol 1982; 118:244-5. (Pubitemid 12142603)
36. Heyer G, Koppert W, Martus P et al. Histamine and cutaneous nociception: Histamine-induced responses in patients with atopic eczema, psoriasis and urticaria. Acta Derm Venereol 1998; 78:123-6. (Pubitemid 28153341)
37. Heyer GR, Hornstein OP. Recent studies of cutaneous nociception in atopic and non-atopic subjects. J Dermatol 1999; 26:77-86. (Pubitemid 29152525)
38. Heyer G, Hornstein OP, Handwerker HO. Reactions to intradermally injected substance P and topically applied mustard oil in atopic dermatitis patients. Acta Derm Venereol 1991; 71:291-5.
39. Ishiuji Y, Coghill RC, Patel TS et al. Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol 2009; 161:1072-80.
40. Schneider G, Stander S, Burgmer M et al. Significant differences in central imaging of histamine-induced itch between atopic dermatitis and healthy subjects. Eur J Pain 2008; 12:834-41.
41. Slater JW, Zechnich AD, Haxby DG. Second-generation antihistamines: A comparative review. Drugs 1999; 57:31-47.
42. Kelsay K. Management of sleep disturbance associated with atopic dermatitis. J Allergy Clin Immunol 2006; 118:198-201. (Pubitemid 43964860)
43. Lever R, Hefni A, Moffatt JD et al. Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses. Clin Exp Allergy 2007; 37:909-17. (Pubitemid 47074561)
44. MacGlashan D Jr. Histamine: A mediator of inflammation. J Allergy Clin Immunol 2003; 112:S53-9. (Pubitemid 37243977)
45. Boone M, Lespagnard L, Renard N et al. Adhesion molecule profiles in atopic dermatitis vs. allergic contact dermatitis: Pharmacological modulation by cetirizine. J Eur Acad Dermatol Venereol 2000; 14:263-6. (Pubitemid 32898917)
46. Zuberbier T, Henz BM. Use of cetirizine in dermatologic disorders. Ann Allergy Asthma Immunol 1999; 83:476-80.
47. Lippert U, Kruger-Krasagakes S, Moller A et al. Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy- loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol 1995; 4:272-6.
48. Molet S, Gosset P, Lassalle P et al. Inhibitory activity of loratadine and descarboxyethoxyloratadine on histamine-induced activation of endothelial cells. Clin Exp Allergy 1997; 27:1167-74. (Pubitemid 27448953)
49. Rossbach K, Wendorff S, Sander K et al. Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 2009; 18:57-63.
50. Dunford PJ, Williams KN, Desai PJ et al. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 2007; 119:176-83. (Pubitemid 46037799)
51. Suzuki K, Morokata T, Morihira K et al. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor. Eur J Pharmacol 2007; 563:224-32. (Pubitemid 46602231)
52. Amano T, Takeda T, Yano H et al. Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice. Br J Dermatol 2007; 156:906-12. (Pubitemid 46642836)
53. Tamura T, Matsubara M, Amano T et al. Olopatadine ameliorates rat experimental cutaneous inflammation by improving skin barrier function. Pharmacology 2008; 81:118-26. (Pubitemid 351182686)
54. Diepgen TL. Early Treatment of the Atopic Child Study G. Long-term treatment with cetirizine of infants with atopic dermatitis: A multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol 2002; 13:278-86. (Pubitemid 35231044)
55. Kawashima M, Tango T, Noguchi T et al. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. Br J Dermatol 2003; 148:1212-21. (Pubitemid 36819222)
56. Berth-Jones J, Graham-Brown RA. Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol 1989; 121:635-7. (Pubitemid 19275251)
57. Wahlgren CF, Hagermark O, Bergstrom R. The antipruritic effect of a sedative and a nonsedative antihistamine in atopic dermatitis. Br J Dermatol 1990; 122:545-51. (Pubitemid 20137375)
58. Hannuksela M, Kalimo K, Lammintausta K et al. Dose ranging study: Cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy 1993; 70:127-33. (Pubitemid 23062807)
59. Kawakami T, Kaminishi K, Soma Y et al. Oral antihistamine therapy influences plasma tryptase levels in adult atopic dermatitis. J Dermatol Sci 2006; 43:127-34. (Pubitemid 44094004)
60. Maurer M, Worm M, Zuberbier T. Antihistamines in atopic dermatitis. In: Reitamo S, Luger T, Steinhoff M, eds. Textbook of Atopic Dermatitis. London: Informa UK Ltd, 2007.
61. Vuurman EF, van Veggel LM, Uiterwijk MM et al. Seasonal allergic rhinitis and antihistamine effects on childresn's learning. Ann Alergy 1993; 71:121-6. (Pubitemid 23245942)
62. Boyle J, Eriksson M, Stanley M et al. Allergy medication in Japanese volunteers: Treatment effect of single doses on nocturnal sleep architecture and next day residual effects. Curr Med Res Opin 2006; 22:1343-51. (Pubitemid 44085586)
63. Williams DH. Skin temperature reaction to histamine in atopic dermatitis (disseminated neurodermatitis). J Invest Dermatol 1938; 1:119-29.